MedTrace Logo

Early Fluid Resuscitation With Balanced HES 130/0.4 [6%] in Severe Burn Injury

NCT01012648 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2011-03-16

No results posted yet for this study

Summary

RCT colloids versus cristalloids only in severe burn victims.

* Trial with medicinal product

Conditions

  • Burns

Interventions

DRUG

Fluid resuscitation

Volume resuscitation

DRUG

HES 130/0.4 (6%), Voluven balanced vs. Lactated Ringer's solution

Volume Resuscitation

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Markus Béchir, M.D: · UniversitaetsSpital Zuerich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01012648 on ClinicalTrials.gov